Concepedia

Publication | Closed Access

Carotid artery revascularization in high surgical risk patients with the NexStent and the Filterwire EX/EZ

96

Citations

26

References

2008

Year

Abstract

The CABERNET trial demonstrates that CAS with NexStent and FilterWire is noninferior to (equivalent or better than) traditional CEA at 1 year in high-surgical-risk patients based on historical controls.

References

YearCitations

Page 1